This information was published on 2025-09-23T11:59:07 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2587853 (IR 1876037) |
| (220) |
18 Aug 2025
|
| (300) |
US, 28 Feb 2025, 99061433
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment and prevention of lymphopenia; pharmaceutical preparations for the treatment and prevention of immunosuppressive side effects of chemotherapy, radiotherapy, and pathogenic infections; pharmaceutical preparations for use in stimulating lymphocyte production; pharmaceutical preparations for maintenance of lymphocyte counts. |
| (540) | ANKTIVOGEN |
| (550) | Word |
| (730) |
ImmunityBio, Inc.
|
Find out more about publications on the About page.